1
TECH
BIO-TECHNE CORP · Health Care
Consensus score 1/100 · #185 this quarter · tier-weighted across tracked managers
↑ConfirmedPrice action since filingas of 2026-07-30
vs 50-day avg
+9.4%
21-day momentum
+22.3%
recent volume
—
13F filings lag ~45 days; this is current price/volume action on top — a technical read, not a prediction.
Holders
2
tracked managers
New this Q
0
opened a position
Avg weight
1.9%
of their portfolios
Combined value
$241M
held, at quarter-end
Who’s holding it Q2 2026, by position size
| Manager | Position size | Value | Change |
|---|---|---|---|
| Ruane Cunniff / Sequoia Quality compounder | 3.7% | $237M | TRIM |
| Glenview Capital Concentrated | 0.1% | $4M | TRIM |
Position size = share of that manager’s reported long US-equity portfolio. The consensus score weights each holder by quality tier, position size, and whether they were buying or trimming — then discounts very crowded names. It measures agreement among these managers, not expected return.